SPAG5 and ovarian cancer: The results showed that compared with the endogenous control gene GAPDH, SPAG5 expression levels in ovarian cancer tissues and paracancerous tissues were 5.36 ± 4.25 and 1.20 ± 1.21 (P = 0.002), respectively (Figure 2A).